Literature DB >> 18381547

First, do no harm.

Daniel K Benjamin1.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18381547      PMCID: PMC2727631          DOI: 10.1542/peds.2008-0068

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  4 in total

1.  Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months.

Authors:  Daniel K Benjamin; Barbara J Stoll; Avory A Fanaroff; Scott A McDonald; William Oh; Rosemary D Higgins; Shahnaz Duara; Kenneth Poole; Abbot Laptook; Ronald Goldberg
Journal:  Pediatrics       Date:  2006-01       Impact factor: 7.124

2.  The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants.

Authors:  C Michael Cotten; Scott McDonald; Barbara Stoll; Ronald N Goldberg; Kenneth Poole; Daniel K Benjamin
Journal:  Pediatrics       Date:  2006-08       Impact factor: 7.124

3.  Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit.

Authors:  C Mary Healy; Carol J Baker; Elena Zaccaria; Judith R Campbell
Journal:  J Pediatr       Date:  2005-08       Impact factor: 4.406

4.  Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species.

Authors:  C Mary Healy; Judith R Campbell; Elena Zaccaria; Carol J Baker
Journal:  Pediatrics       Date:  2008-04       Impact factor: 7.124

  4 in total
  2 in total

Review 1.  Risk factors and prevention of late-onset sepsis in premature infants.

Authors:  L Corbin Downey; P Brian Smith; Daniel K Benjamin
Journal:  Early Hum Dev       Date:  2010-01-29       Impact factor: 2.079

Review 2.  Pediatric antifungal agents.

Authors:  Michael Cohen-Wolkowiez; Cassandra Moran; Daniel K Benjamin; Phillip B Smith
Journal:  Curr Opin Infect Dis       Date:  2009-12       Impact factor: 4.915

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.